Inactive Instrument

Highlights Tengion, Inc. Other OTC

Equities

RegenMedTX, LLC completed the acquisition of substantially all assets from Tengion, Inc. (OTCPK:TNGN.Q).	15-03-31	CI
RegenMedTX, LLC signed an agreement to acquire substantially all assets from Tengion, Inc. (OTCPK:TNGN.Q) for $22.1 million.	15-02-11	CI
Tengion, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014	14-11-14	CI
Tengion, Inc. Announces Unaudited Earnings Results for Second Quarter and Six Months Ended June 30, 2014; Provides Clinical Update	14-08-13	CI
Tengion, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2014	14-05-15	CI
Tengion, Inc. Announces Continued Clinical Progress in its Two Lead Programs	14-01-13	CI
Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden	13-04-01	CI
Tengion, Inc. Announces Clinical Progress for Neo-Urinary Conduit Phase 1 Trial and Regulatory Advance for Neo-Kidney Augment	13-01-30	CI
Tengion Provides Patient Update on its Neo-Urinary Conduit(TM) Clinical Program	12-10-26	CI
Tengion, Inc. Announces Continued Clinical Progress on Key Milestones for Neo-Urinary Conduit(TM)	12-06-11	CI
Tengion, Inc. Announces Significant Advances in Neo-Urinary Conduit and Neo-Kidney Augment Programs	12-03-26	CI

No results for this search